894 related articles for article (PubMed ID: 21228259)
81. Cinacalcet corrects biased allosteric modulation of CaSR by AHH autoantibody.
Makita N; Ando T; Sato J; Manaka K; Mitani K; Kikuchi Y; Niwa T; Ootaki M; Takeba Y; Matsumoto N; Kawakami A; Ogawa T; Nangaku M; Iiri T
JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996138
[TBL] [Abstract][Full Text] [Related]
82. Impact of clinically relevant mutations on the pharmacoregulation and signaling bias of the calcium-sensing receptor by positive and negative allosteric modulators.
Leach K; Wen A; Cook AE; Sexton PM; Conigrave AD; Christopoulos A
Endocrinology; 2013 Mar; 154(3):1105-16. PubMed ID: 23372019
[TBL] [Abstract][Full Text] [Related]
83. Conserved Residues Control the T1R3-Specific Allosteric Signaling Pathway of the Mammalian Sweet-Taste Receptor.
Chéron JB; Soohoo A; Wang Y; Golebiowski J; Antonczak S; Jiang P; Fiorucci S
Chem Senses; 2019 May; 44(5):303-310. PubMed ID: 30893427
[TBL] [Abstract][Full Text] [Related]
84. Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.
Reinecke BA; Wang H; Zhang Y
Curr Top Med Chem; 2019; 19(26):2378-2392. PubMed ID: 31833462
[TBL] [Abstract][Full Text] [Related]
85. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
Janero DR; Thakur GA
Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
[TBL] [Abstract][Full Text] [Related]
86. Allosteric modulation of G protein-coupled receptors.
May LT; Avlani VA; Sexton PM; Christopoulos A
Curr Pharm Des; 2004; 10(17):2003-13. PubMed ID: 15279541
[TBL] [Abstract][Full Text] [Related]
87. New insights into the characteristics of sweet and bitter taste receptors.
Temussi PA
Int Rev Cell Mol Biol; 2011; 291():191-226. PubMed ID: 22017977
[TBL] [Abstract][Full Text] [Related]
88. The best of both worlds? Bitopic orthosteric/allosteric ligands of g protein-coupled receptors.
Valant C; Robert Lane J; Sexton PM; Christopoulos A
Annu Rev Pharmacol Toxicol; 2012; 52():153-78. PubMed ID: 21910627
[TBL] [Abstract][Full Text] [Related]
89. Structure and function of the human calcium-sensing receptor: insights from natural and engineered mutations and allosteric modulators.
Hu J; Spiegel AM
J Cell Mol Med; 2007; 11(5):908-22. PubMed ID: 17979873
[TBL] [Abstract][Full Text] [Related]
90. Biased ligands for better cardiovascular drugs: dissecting G-protein-coupled receptor pharmacology.
DeWire SM; Violin JD
Circ Res; 2011 Jul; 109(2):205-16. PubMed ID: 21737816
[TBL] [Abstract][Full Text] [Related]
91. Regulation of stability and trafficking of calcium-sensing receptors by pharmacologic chaperones.
Huang Y; Cavanaugh A; Breitwieser GE
Adv Pharmacol; 2011; 62():143-73. PubMed ID: 21907909
[TBL] [Abstract][Full Text] [Related]
92. Advances in G protein-coupled receptor allostery: from function to structure.
Christopoulos A
Mol Pharmacol; 2014 Nov; 86(5):463-78. PubMed ID: 25061106
[TBL] [Abstract][Full Text] [Related]
93. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
Lu S; Zhang J
J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
[TBL] [Abstract][Full Text] [Related]
94. A simple method to detect allostery in GPCR dimers.
Goupil E; Laporte SA; Hébert TE
Methods Cell Biol; 2013; 117():165-79. PubMed ID: 24143977
[TBL] [Abstract][Full Text] [Related]
95. GPCR drug discovery-moving beyond the orthosteric to the allosteric domain.
Felder CC
Adv Pharmacol; 2019; 86():1-20. PubMed ID: 31378249
[TBL] [Abstract][Full Text] [Related]
96. Activation mechanism of the G protein-coupled sweet receptor heterodimer with sweeteners and allosteric agonists.
Kim SK; Chen Y; Abrol R; Goddard WA; Guthrie B
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2568-2573. PubMed ID: 28228527
[TBL] [Abstract][Full Text] [Related]
97. Keynote review: allosterism in membrane receptors.
Gao ZG; Jacobson KA
Drug Discov Today; 2006 Mar; 11(5-6):191-202. PubMed ID: 16580596
[TBL] [Abstract][Full Text] [Related]
98. Quantification of allosteric interactions at G protein-coupled receptors using radioligand binding assays.
Leach K; Sexton PM; Christopoulos A
Curr Protoc Pharmacol; 2011 Mar; Chapter 1():Unit 1.22. PubMed ID: 21935902
[TBL] [Abstract][Full Text] [Related]
99. Allosteric modulators of G-protein-coupled receptors.
May LT; Christopoulos A
Curr Opin Pharmacol; 2003 Oct; 3(5):551-6. PubMed ID: 14559102
[TBL] [Abstract][Full Text] [Related]
100. Determination of different putative allosteric binding pockets at the lutropin receptor by using diverse drug-like low molecular weight ligands.
Heitman LH; Kleinau G; Brussee J; Krause G; Ijzerman AP
Mol Cell Endocrinol; 2012 Apr; 351(2):326-36. PubMed ID: 22269095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
